Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Liver Cirrhosis 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 8 pembrolizumab 5 Cisplatin 5 enfortumab vedotin 3 avelumab 3 Specimen Handling 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Carboplatin 3 vinflunine 2 Radiotherapy 2 Nephroureterectomy 2 Immunoglobulin G 2 Doxorubicin 2 Disulfides 2 vandetanib 1 tremelimumab 1 tocilizumab 1 tamibarotene 1 relatlimab 1 pegfilgrastim 1 merphos 1 guadecitabine 1 genexol-PM 1 enzalutamide 1 durvalumab 1 dehydroftorafur 1 atezolizumab 1 abexinostat 1 Vitamin D 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ureteral Neoplasms × Plasmapheresis × Clear all

NCT07087860 2026-05-08

RECIPE-B1

Mayo Clinic

Phase 2 Recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡